ArticleAntibiotics (Basel, Switzerland)2024

Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria.

Cristina Kirkegaard-Biosca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.